THEMISMED132.00

Themis Medicare Limited

· Pharma & Health
₹ CrorePeersLINCOLNBAJAJHCARESIGACHIWANBURYAMRUTANJANAHCLANUHPHRMcap ₹1,216 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation12.29.910.3
+ Impairment Loss / (Reversal)-0.00.00.0
+ Finance Costs0.08.50.0
+ Interest Income0.0-1.10.0
+ Dividend Income-2.4-0.40.0
+ Fair Value (Gains) / Losses-0.10.0-0.0
+ Unrealised FX (Gain) / Loss0.00.00.0
+ Other Non-cash Items0.00.00.0
+ Other — Cash Effects are Investing / Financing0.0-0.10.0
Changes in Working Capital
+ Inventories-1.6-13.73.2
+ Trade Receivables — Current-32.90.8-1.0
+ Other Financial Assets — Non-current0.0-1.40.0
+ Other Current Assets5.80.0-0.2
+ Other Non-current Assets0.0-3.2-6.8
+ Other Bank Balances-3.03.11.7
+ Trade Payables — Current7.24.1-0.6
+ Other Financial Liabilities — Current2.80.01.5
+ Other Financial Liabilities — Non-current0.24.10.0
+ Other Current Liabilities0.00.20.0
+ Other Non-current Liabilities0.00.0-0.4
+ Provisions — Current0.60.00.7
+ Provisions — Non-current0.00.70.0
Cash from Operating Activities
Profit Before Tax (per I/S)34.633.7-12.137.8
+ Total Adjustments (incl. Working Capital)-11.211.78.3
Cash from Operations (pre-tax)23.445.5-3.8
+ Interest Paid — Operating0.00.0-8.9
+ Dividends Received — Operating0.00.0-2.0
+ Income Taxes Paid9.010.86.4
Cash from Operating Activities14.534.7-3.3
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)18.415.44.9
+ Disp of Fixed Assets0.01.70.4
+ Disp of Investment Property0.00.00.0
+ Dividends Received — Investing1.60.41.7
+ Interest Received — Investing0.81.10.3
Cash from Investing Activities-15.9-12.2-2.5
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.2
+ Proceeds from Borrowings5.50.017.1
+ Repayment of Borrowings1.712.80.0
+ Payment of Lease Liabilities0.40.00.0
+ Interest Paid0.08.58.9
+ Dividends Paid4.64.64.6
Cash from Financing Activities-1.1-25.93.8
Net Changes in Cash (pre-FX)-2.6-3.4-2.0
Net Changes in Cash-2.6-3.4-2.0
Closing Cash9.9
Reference Items
EBITDA51.549.00.4-41.9
EBITDA Margin %13.4912.100.11-12.65
Free Cash Flow (CFO − Capex)-4.019.3-8.1-8.1
Free Cash Flow to Equity-2.00.1
Free Cash Flow per Basic Share-0.432.09-0.88-0.88
Cash Flow to Net Income0.331.16-2.86
Cash Paid for Taxes9.010.86.4
Cash Paid for Interest0.08.58.9
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.